Badgley, Phelps & Bell’s Bristol-Myers Squibb BMY Stock Holding History

Badgley, Phelps & Bell’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$644K	Buy	9,639 +1,417	+17%	+$92.4K	0.02%	150
2021 Q1	$519K	Sell	8,222 -1,598	-16%	-$99.4K	0.02%	153
2020 Q4	$609K	Buy	9,820 +566	+6%	+$34.8K	0.03%	144
2020 Q3	$558K	Sell	9,254 -49	-0.5%	-$2.95K	0.03%	142
2020 Q2	$547K	Sell	9,303 -90	-1%	-$5.38K	0.03%	139
2020 Q1	$524K	Sell	9,393 -1,213	-11%	-$74.1K	0.03%	130
2019 Q4	$681K	Buy	+10,606	New	+$607K	0.04%	133
2018 Q1	–	Sell	-4,189	Closed	-$257K	–	189
2017 Q4	$257K	Buy	4,189 +1,049	+33%	+$65.6K	0.02%	173
2017 Q3	$200K	Buy	+3,140	New	+$183K	0.01%	154

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Badgley, Phelps & Bell's BMY Position: Q2 2021 in Review

Badgley, Phelps & Bell increased its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2021, buying an estimated $92.4K and bringing the position to 9,639 shares worth $644K. The position accounts for 0.02% of the portfolio, ranked #150.

Badgley, Phelps & Bell first reported a position in BMY in Q3 2017 and has held it in 9 quarters since. The position peaked at $681K in Q4 2019. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Badgley, Phelps & Bell held 9,639 shares of Bristol-Myers Squibb worth $644K as of Q2 2021.
Badgley, Phelps & Bell bought 1,417 Bristol-Myers Squibb shares in Q2 2021, an estimated $92.4K.
Bristol-Myers Squibb made up 0.02% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #150 holding.
Badgley, Phelps & Bell first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 9 quarters since.
Badgley, Phelps & Bell's Bristol-Myers Squibb position peaked at $681K in Q4 2019.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.